New CEOs in pharmaceutical industry facing challenge

Published: 2009-03-18 07:00:00

Updated: 2009-03-18 07:00:00

Local pharmaceutical firms are likely to face their biggest challenges this year due to the deepening economic downturn; so too will be heads of the leading pharmaceutical firms.

Experts said a number of newly appointed or incumbent CEOs will be an uneasy footing.

With the prolonged busine...

Fees

- Email service daily and homepage access.

$300 per month. ($3,240 per year)
5 Email holders per each company.
Anual contract base.

Latest News

Which are outstanding tetravalent vaccines even for the young?

Disease treated the most with clinical trial drugs is respiratory disorder like lung cancer

Who will be the next Pharmaceutical Safety Bureau Director?

Celltrion completes clinical trials for Remsima SC for European approval

Sales listed pharmas made in the first half of the year

TOP

BACK